American Tungsten Corp.
DEMRF
$0.6955
$0.02133.16%
| Weiss Ratings | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -15.06% | |||
| 30-Day Total Return | -18.18% | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | 73.88% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -59.09% | |||
| 52-Week Low % Change | 99.08% | |||
| Price | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.70 | |||
| 52-Week Low Price | $0.35 | |||
| 52-Week Low Price (Date) | Dec 17, 2024 | |||
| 52-Week High Price (Date) | Feb 12, 2025 | |||
| Valuation | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 16.58M | |||
| Enterprise Value | 16.57M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | 2.83% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -133.75 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.70 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -58.79 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 15.49M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 647-328-8227 | |||
| Address | 335 - 1632 Dickson Avenue Kelowna, BC V1Y 7T2 | |||
| Website | americantungstencorp.com | |||
| Country | Canada | |||
| Year Founded | 2019 | |||
| Profitability | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -195.87% | |||
| Return on Equity | -- | |||
| Income Statement | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 94.60K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -281.90K | |||
| Net Income (TTM) | -282.40K | |||
| Net Income Avl. to Common (TTM) | -282.40K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 49.19% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | 50.00% | |||
| Balance Sheet | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.80K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 18.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -80.80K | |||
| Current Ratio (Q) | 0.183 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 18.10K | |||
| Total Current Liabilities (Q) | 99.00K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 99.00K | |||
| Total Common Equity (Q) | -80.80K | |||
| Cash Flow | DEMRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 88.20K | |||
| Net Change in Cash (TTM) | -132.40K | |||
| Levered Free Cash Flow (TTM) | 36.90K | |||
| Cash from Operations (TTM) | -220.60K | |||
